In this article from MedPage Today, drinking green tea and coffee was associated with reduced all-cause mortality in Japanese patients with type 2 diabetes, especially those who drank both, researchers reported. In a cohort study that followed nearly 5,000 patients for approximately 5 years, the researchers found a dose-response relationship for both beverages.
In this Original Investigation from JAMA Oncology, the authors attempt to discover whether increased coffee consumption is associated with improved survival in patients with advanced or metastatic colorectal cancer. Overall survival (OS) and progression-free survival (PFS) were the main outcomes and measures, and both decaffeinated and caffeinated coffee were studied.
A JAMA “Original Investigation” seeks to discover the characteristics, clinical presentation, and outcomes of 5,700 patients hospitalized with COVID-19 in the United States, specifically in the New York City area.
Longer overall survival and similar safety profile were the endpoints in this NEJM piece, comparing those who received osimertinib with those who received a comparator EGFR-TKI.